Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor

Emerg Microbes Infect. 2021 Dec;10(1):1507-1514. doi: 10.1080/22221751.2021.1956373.

Abstract

Severe respiratory disease coronavirus-2 (SARS-CoV-2) has been the most devastating disease COVID-19 in the century. One of the unsolved scientific questions of SARS-CoV-2 is the animal origin of this virus. Bats and pangolins are recognized as the most probable reservoir hosts that harbour highly similar SARS-CoV-2 related viruses (SARSr-CoV-2). This study identified a novel lineage of SARSr-CoVs, including RaTG15 and seven other viruses, from bats at the same location where we found RaTG13 in 2015. Although RaTG15 and the related viruses share 97.2% amino acid sequence identities with SARS-CoV-2 in the conserved ORF1b region, it only shows less than 77.6% nucleotide identity to all known SARSr-CoVs at the genome level, thus forming a distinct lineage in the Sarbecovirus phylogenetic tree. We found that the RaTG15 receptor-binding domain (RBD) can bind to ACE2 from Rhinolophus affinis, Malayan pangolin, and use it as an entry receptor, except for ACE2 from humans. However, it contains a short deletion and has different key residues responsible for ACE2 binding. In addition, we showed that none of the known viruses in bat SARSr-CoV-2 lineage discovered uses human ACE2 as efficiently as the pangolin-derived SARSr-CoV-2 or some viruses in the SARSr-CoV-1 lineage. Therefore, further systematic and longitudinal studies in bats are needed to prevent future spillover events caused by SARSr-CoVs or to understand the origin of SARS-CoV-2 better.

Keywords: ACE2; SARS-related coronavirus; bat; novel lineage; reservoir host.

MeSH terms

  • Angiotensin-Converting Enzyme 2 / physiology*
  • Animals
  • Cell Lineage*
  • Chiroptera / virology*
  • Host Specificity
  • Phylogeny
  • SARS-CoV-2 / classification*
  • Severe acute respiratory syndrome-related coronavirus / classification
  • Severe acute respiratory syndrome-related coronavirus / isolation & purification*

Substances

  • Angiotensin-Converting Enzyme 2

Grants and funding

This work was jointly supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010101 to Z-L.S) and the China National Science Foundation (81822028 to P.Z and 81290341 to Z-L.S).